1,219
Views
2
CrossRef citations to date
0
Altmetric
Oncology

The issue of financial toxicity in the management of chronic myeloid leukemia with blast crisis

ORCID Icon
Pages 709-711 | Received 28 Feb 2018, Accepted 09 Apr 2018, Published online: 08 May 2018
 

Transparency

Declaration of funding

No funding is reported for this manuscript.

Declaration of financial/other relationships

AEE has received honoraria for advisory board membership from Novartis, and has received lecture fees from Novartis and Bristol-Myers Squibb. JME peer reviewers on this manuscript have no relevant financial or other relationships to disclose.

Acknowledgements

AEE would like to thank retired Prof. Birsen Ulku for influencing him in choosing a career in hematology.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.